LifeStance legal chief Ryan Pardo sells 587,920 shares

Available on EDGAR 11/13/2026 - 09:05 PM EST Accepted by SEC EDGAR 11/13/2026 - 09:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

LifeStance Health Group, Inc. (LFST) Chief Legal Officer and Secretary Ryan Pardo reported selling 587,920 directly held shares on November 10, 2026, at a weighted average of $14.58 per share under a Rule 10b5-1(c) plan adopted August 11, 2026. A further 2,216,585 shares held of record by Kimberly Pardo Irrevocable Trust were sold that day at the same weighted average under a plan adopted August 10, 2026; Pardo disclaims beneficial ownership except to the extent of his pecuniary interest. Both sales were at prices ranging from $14.285 to $14.7878 per share. After the transactions, reported direct holdings were 505,446 shares and trust-held shares were 334,935.

Insider Trade Summary 10b5-1

Net Seller: 2,804,505 shares

Net Sell 2 txns

Insider Pardo Ryan

Role See Remarks

Sold 2,804,505 shs ($40.89M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	587,920	$14.58	$8.57M
Sale	Common Stock F3, F4, F5	2,216,585	$14.58	$32.32M

Holdings After Transaction: Common Stock — 505,446 shares (Direct); Common Stock — 334,935 shares (Indirect, By Trust)

Footnotes (5)

1. F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2. F2. Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026.
3. F3. Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026.
4. F4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
5. F5. Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

Key Figures

Direct shares sold: 587,920 shares Trust-record shares sold: 2,216,585 shares Weighted average sale price: $14.58 per share +3 more

6 metrics

Direct shares sold 587,920 shares Ryan Pardo's reported sale on November 10, 2026

Trust-record shares sold 2,216,585 shares Shares held of record by Kimberly Pardo Irrevocable Trust; sale reported on November 10, 2026

Weighted average sale price $14.58 per share Both reported sales on November 10, 2026

Sale price range $14.285 to $14.7878 per share Range reported for both sales

Direct shares following transactions 505,446 shares Ryan Pardo's reported direct holdings after the transactions

Trust-record shares following transactions 334,935 shares Reported holdings following the transactions

Key Terms

Rule 10b5-1(c), weighted average price, pecuniary interest

3 terms

Rule 10b5-1(c) regulatory

"under a Rule 10b5-1(c) plan adopted August 11, 2026"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

weighted average price financial

"The price reported is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

pecuniary interest regulatory

"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What LFST shares did Ryan Pardo and the Kimberly Pardo Irrevocable Trust sell?

Ryan Pardo reported selling 587,920 directly held shares, and 2,216,585 shares held of record by Kimberly Pardo Irrevocable Trust were sold on November 10, 2026. Both sales had a weighted average price of $14.58 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pardo Ryan

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2026		S(1)		587,920(2)	D	$14.58	505,446	D
Common Stock	11/10/2026		S(3)		2,216,585(4)	D	$14.58	334,935	I	By Trust(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

2. Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 11, 2026.

3. Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on August 10, 2026.

4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.285 to $14.7878 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.

Remarks:

Chief Legal Officer and Secretary

	By: /s/ Ryan Pardo	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)